FR2689012A1 - Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires. - Google Patents
Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires. Download PDFInfo
- Publication number
- FR2689012A1 FR2689012A1 FR9203747A FR9203747A FR2689012A1 FR 2689012 A1 FR2689012 A1 FR 2689012A1 FR 9203747 A FR9203747 A FR 9203747A FR 9203747 A FR9203747 A FR 9203747A FR 2689012 A1 FR2689012 A1 FR 2689012A1
- Authority
- FR
- France
- Prior art keywords
- group
- naphthyl
- compound
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003118 aryl group Chemical group 0.000 title abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 title description 4
- 230000003205 diastolic effect Effects 0.000 claims abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 19
- -1 3-phenanthryl Chemical group 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 3
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 2
- ZBBCZHQAXDJXPG-UHFFFAOYSA-N 6-naphthalen-2-yl-3-(2H-tetrazol-5-yl)-1H-pyridin-2-one Chemical compound C1=C(C=CC2=CC=CC=C12)C1=CC=C(C(N1)=O)C1=NN=NN1 ZBBCZHQAXDJXPG-UHFFFAOYSA-N 0.000 claims description 2
- 229910006069 SO3H Inorganic materials 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 2
- CUJPFPXNDSIBPG-UHFFFAOYSA-N 1,3-propanediyl Chemical group [CH2]C[CH2] CUJPFPXNDSIBPG-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000003295 lusitropic effect Effects 0.000 abstract description 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 3
- XJQFJIRQMZZIOB-UHFFFAOYSA-N 6-(2-pentoxynaphthalen-1-yl)-3-(2H-tetrazol-5-yl)-1H-pyridin-2-one Chemical compound C(CCCC)OC1=C(C2=CC=CC=C2C=C1)C1=CC=C(C(N1)=O)C1=NN=NN1 XJQFJIRQMZZIOB-UHFFFAOYSA-N 0.000 description 2
- 230000010117 myocardial relaxation Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9203747A FR2689012A1 (fr) | 1992-03-27 | 1992-03-27 | Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires. |
| EP93906752A EP0632724A1 (en) | 1992-03-27 | 1993-03-25 | Phenol and pyridinol derivatives as lusitropic agents |
| CA002132981A CA2132981A1 (en) | 1992-03-27 | 1993-03-25 | Phenol and pyridinol derivatives as lusitropic agents |
| PCT/GB1993/000615 WO1993019754A1 (en) | 1992-03-27 | 1993-03-25 | Phenol and pyridinol derivatives as lusitropic agents |
| JP5517196A JPH07508707A (ja) | 1992-03-27 | 1993-03-25 | ルシトロピック剤用フェノールおよびピリジノール誘導体 |
| AU37646/93A AU3764693A (en) | 1992-03-27 | 1993-03-25 | Phenol and pyridinol derivatives as lusitropic agents |
| TW082102673A TW234086B (enrdf_load_stackoverflow) | 1992-03-27 | 1993-04-09 | |
| KR1019940703385A KR950700736A (ko) | 1992-03-27 | 1994-09-26 | 루시트로픽제로서 페놀 및 피리디놀 유도체(Phenol and pyridinol derivatives as lusitropic agents) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9203747A FR2689012A1 (fr) | 1992-03-27 | 1992-03-27 | Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2689012A1 true FR2689012A1 (fr) | 1993-10-01 |
Family
ID=9428178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9203747A Pending FR2689012A1 (fr) | 1992-03-27 | 1992-03-27 | Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires. |
Country Status (8)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2753722A1 (fr) * | 1996-09-26 | 1998-03-27 | Smithkline Beecham Lab | Procede de detection de modulateurs de relaxation cardiaque et modulateurs ainsi obtenus |
| TWI486165B (zh) | 2011-02-15 | 2015-06-01 | Univ China Medical | 用於抑制血管狹窄之醫藥組合物及萃取物與該等之應用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ234186A (en) * | 1989-07-07 | 1991-10-25 | Janssen Pharmaceutica Nv | Imidazo quinazolin-one derivatives and pharmaceutical compositions |
| WO1991017987A1 (en) * | 1990-05-21 | 1991-11-28 | Smith Kline & French Laboratories Limited | Phenol and pyridinol derivatives as pharmaceuticals |
| CA2091989A1 (en) * | 1990-09-28 | 1992-03-29 | Roderick Alan Porter | Phenylpyridinol derivatives as medicaments |
-
1992
- 1992-03-27 FR FR9203747A patent/FR2689012A1/fr active Pending
-
1993
- 1993-03-25 CA CA002132981A patent/CA2132981A1/en not_active Abandoned
- 1993-03-25 WO PCT/GB1993/000615 patent/WO1993019754A1/en not_active Application Discontinuation
- 1993-03-25 AU AU37646/93A patent/AU3764693A/en not_active Abandoned
- 1993-03-25 EP EP93906752A patent/EP0632724A1/en not_active Withdrawn
- 1993-03-25 JP JP5517196A patent/JPH07508707A/ja active Pending
- 1993-04-09 TW TW082102673A patent/TW234086B/zh active
-
1994
- 1994-09-26 KR KR1019940703385A patent/KR950700736A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07508707A (ja) | 1995-09-28 |
| AU3764693A (en) | 1993-11-08 |
| KR950700736A (ko) | 1995-02-20 |
| TW234086B (enrdf_load_stackoverflow) | 1994-11-11 |
| CA2132981A1 (en) | 1993-10-14 |
| WO1993019754A1 (en) | 1993-10-14 |
| EP0632724A1 (en) | 1995-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2492258A1 (fr) | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole | |
| RU2001103136A (ru) | Ингибиторы наладазы (naaladase), полезные в качестве фармацевтических соединений и композиций | |
| RU96120174A (ru) | Производные нафталина | |
| FR2525604A2 (fr) | Acides aza bicyclo heptane carboxyliques substitues, leur preparation et leur application en therapeutique | |
| EP0202157B1 (fr) | Amino-2 thiazoles N-substitués, leur procédé de préparation et leur application en thérapeutique | |
| EP0515265A1 (fr) | Nouveaux dérivés de la pyrimidine, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant | |
| US5491159A (en) | 2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-oxazoles as anti-atherosclerotic agents | |
| EP0461039B1 (fr) | Dérivés du benzimidazole, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant | |
| EP0087378B1 (fr) | Ethers-oximes d'alcoylaminoalcools comme médicaments, produits nouveaux et procédés pour leur préparation | |
| EP0579819B1 (fr) | Nouveau derive de la pyridone ayant une affinite pour le recepteur a l'angiotensine ii | |
| EP1572180B1 (en) | Use of alpha-phenylthiocarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity | |
| FR2689012A1 (fr) | Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires. | |
| EP0632026B1 (fr) | Nouveaux dérivés d'alpha amino acides leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| CH620675A5 (enrdf_load_stackoverflow) | ||
| EP0262053A2 (fr) | Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| EP1165491B1 (fr) | Inhibiteurs de lta4 hydrolase | |
| EP0021924B1 (fr) | Dérivés de l'indole, procédé pour leur préparation, leur application comme médicaments et compositions pharmaceutiques les contenant | |
| US4469705A (en) | Saturated leukotriene derivatives as antiallergens | |
| FR2553663A1 (fr) | Derives du 1,2-dithiolanne, leur preparation et leur utilisation comme medicaments | |
| FR2641534A1 (fr) | Nouveaux derives de glycine utiles comme medicaments antagonistes du thromboxane a2 et procede pour leur preparation | |
| FR2558161A1 (fr) | 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique | |
| EP0244318B1 (fr) | Nouveaux dérivés de la N-[(triméthoxy-2,4,6-benzoyl)-3 propyl] pipéridine, leurs procédés de préparation et leur application en thérapeutique | |
| EP0012072A2 (fr) | Bêta-lactones dérivées de l'acide 2-hydroxy cyclopentane carboxylique, procédé pour leur préparation et compositions pharmaceutiques les renfermant | |
| FR2467598A1 (fr) | Composition dermatologique contenant un ou plusieurs triglycerides et son application au traitement de la peau vivante | |
| KR930021203A (ko) | 죽상동맥경화 치료제로서의 독사조신의 히드록실화된 대사산물 및 유도체 |